Fortrea (FTRE) Shares Skyrocket, What You Need To KnowWhat Happened? Shares of clinical research company Fortrea Holdings (
NASDAQ:FTRE) jumped 20.3% in the morning session after it reported first-quarter 2026 re...
Fortrea’s (NASDAQ:FTRE) Q1 CY2026 Sales Beat Estimates, Stock SoarsClinical research company Fortrea Holdings (
NASDAQ:FTRE) announced better-than-expected revenue in Q1 CY2026, but sales fell by 2.3% year on year to $636.5 m...
Fortrea Reports First Quarter 2026 ResultsStrong first-quarter performance reinforces confidence in FY 2026 guidanceBook-to-bill of 1.15x is third consecutive quarter above 1.1x
Fortrea (FTRE) Q1 Earnings: What To ExpectClinical research company Fortrea Holdings (
NASDAQ:FTRE) will be reporting earnings this Tuesday before market open. Here’s what to look for. Fortrea missed ...
3 Small-Cap Stocks with Questionable FundamentalsSmall-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and...
2 of Wall Street’s Favorite Stocks to Consider Right Now and 1 We QuestionThe stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these f...
Fortrea Announces Date for First Quarter 2026 Financial Results and Conference CallDURHAM, N.C., April 21, 2026 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced that it will release its first quarter 2026 financial results before the market opens on Tuesday, May 5, 2026. The Company will host a conference call at 8:00 a.m. ET on that day to discuss the results.
3 Reasons to Avoid FTRE and 1 Stock to Buy InsteadFortrea has been treading water for the past six months, recording a small loss of 1.7% while holding steady at $9.39. Is there a buying opportunity in Fortr...
Astrana Health, Evolent Health, Neogen, agilon health, and Fortrea Shares Are Soaring, What You Need To KnowWhat Happened? A number of stocks jumped in the afternoon session after the government announced a surprise increase in payment rates for Medicare Advantage ...
Fortrea Unveils Fortrea Intelligent Technology™ to Help Sponsors and Sites Run Smarter, More Integrated TrialsAI-enhanced suite of solutions features new and improved technology to empower efficiency, confidence and quality
Guardant Health, Organon, Fortrea, QuidelOrtho, and Charles River Laboratories Stocks Trade Down, What You Need To KnowWhat Happened? A number of stocks fell in the afternoon session after a proposed 2027 federal budget revealed significant spending cuts for key health agenci...
Elanco, Tandem Diabetes, Fortrea, Natera, and Myriad Genetics Shares Plummet, What You Need To KnowWhat Happened? A number of stocks fell in the afternoon session after major indices including the S&P 500 and Dow Jones Industrial Average fell sharply as in...
1 Healthcare Stock to Consider Right Now and 2 We Turn DownPersonal health and wellness is one of the many secular tailwinds for healthcare companies. Those leading the charge have not only realized strong financial ...
Why Fortrea (FTRE) Stock Is Up TodayWhat Happened? Shares of clinical research company Fortrea Holdings (
NASDAQ:FTRE) jumped 2.8% in the afternoon session after TD Cowen upgraded the company to...
Fortrea, Alignment Healthcare, PacBio, DexCom, and Humana Stocks Trade Up, What You Need To KnowWhat Happened? A number of stocks jumped in the afternoon session after easing crude oil prices helped lift investor sentiment and reduce inflation worries. ...
3 Small-Cap Stocks with Open QuestionsMany small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that ...
Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)DURHAM, N.C., March 10, 2026 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization, today announced the granting of an inducement award of restricted stock units (“RSUs”) on March 10, 2026, to four newly hired employees. The award consisted of 130,000 RSUs that vest in three equal annual installments starting March 10, 2027, subject to the employee’s continuous employment through the applicable vesting date. The RSUs are subject to the terms and conditions of the Company’s Amended and Restated 2025 Inducement Award Plan and the award agreements covering the grants. These awards follow Nasdaq Listing Rule 5635(c)(4) and are intended as an inducement material to the individual becoming a new employee of the Company.
3 Stocks Under $50 Walking a Fine LineThe $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk tha...
Option Care Health, CooperCompanies, Neogen, GoodRx, and Fortrea Shares Are Falling, What You Need To KnowA number of stocks fell in the afternoon session after the February jobs report revealed an unexpected contraction in employment, with the healthcare industry showing significant job losses.
Q4 Earnings Highs And Lows: Fortrea (NASDAQ:FTRE) Vs The Rest Of The Drug Development Inputs & Services StocksAs the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the drug development inputs & services industry, including Fortrea (
NASDAQ:FTRE) and its peers.
Fortrea (NASDAQ:FTRE) Reports Sales Below Analyst Estimates In Q4 CY2025 EarningsClinical research company Fortrea Holdings (
NASDAQ:FTRE) fell short of the market’s revenue expectations in Q4 CY2025, with sales falling 5.2% year on year to $660.5 million. The company’s full-year revenue guidance of $2.6 billion at the midpoint came in 4.9% below analysts’ estimates. Its non-GAAP profit of $0.09 per share was 43.8% below analysts’ consensus estimates.
